| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8450414 | Experimental Cell Research | 2018 | 32 Pages |
Abstract
CDK8 promotes angiogenesis in pancreatic cancer via activation of the CDK8-β-catenin-KLF2 signaling axis, thus providing valid targets for the treatment of pancreatic cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ran Wei, Lingdong Kong, Yuhong Xiao, Huiping Yuan, Yi Song, Jia Wang, Huihuan Yu, Shengxun Mao, Wei Xu,